Oxamflatin
-
Catalog number2250-1
-
PricePlease ask
-
Size1 mg
-
-
Alternative_nameN-hydroxy-5-[3-[(phenylsulfonyl)amino]phenyl]-2E-penten-4-ynamide; Metacept 3
-
DescriptionA potent inhibitor of mammalian histone deacetylases (HDACs) (IC₅₀ = 15.7 nM). A novel antitumor agent; oxamflatin modifies epigenetic status and gene expression, increases blastocyst quality, and subsequently enhances the nuclear reprogramming and developmental potential of SCNT (somatic cell nuclear transfer) embryos.
-
CAS Number151720-43-3
-
Structure AvailableYes
-
Salt FormNo
-
Molecular FormulaC₁₇H₁₄N₂O₄S
-
Molecular Weight342.37
-
Cell PermeableYes
-
Purity≥95%
-
SolubilitiesDMSO (5 mg/ml) or EtOH (0.5 mg/ml)
-
HandlingProtect from light and moisture
-
Tag LineA potent inhibitor of mammalian histone deacetylases (HDACs)
-
Storage Condition-20°C
-
Shipping Conditiongel pack
-
Shelf Life24 months
-
MDL NumberMFCD00949087
-
PubChem CID5353852
-
SMILESC1=CC=C(C=C1)S(=O)(=O)NC2=CC=CC(=C2)C#CC=CC(=O)NO
-
InChiInChI=1S/C17H14N2O4S/c20-17(18-21)12-5-4-7-14-8-6-9-15(13-14)19-24(22,23)16-10-2-1-3-11-16/h1-3,5-6,8-13,19,21H,(H,18,20)/b12-5+
-
InChi KeyQRPSQQUYPMFERG-LFYBBSHMSA-N
-
MSDS AvailableYes
-
Gene target
-
Short nameOxamflatin
-
Alternative nameOxamflatin
-